Canada’s Shoppers Drug Mart to kick off ‘This Summer – Only at Shoppers’ campaign
TORONTO — Canadian pharmacy retailer Shoppers Drug Mart is launching on Saturday a new campaign, dubbed “This Summer – Only at Shoppers,” to introduce hundreds of exclusive products and an interactive online portal.
“We’re all looking forward to the warmer weather and spending more time outside, especially after the winter we just had,” stated Chong Bang, SVP merchandising for Shoppers Drug Mart. “We want to help Canadians get the most out of summer by offering great new products, seasonal tips and a chance to win valuable prizes.”
The new Only at Shoppers online portal shares seasonal trends, tips and product picks from popular Canadian bloggers and experts in the realm of health, fitness, beauty and parenting. Features include articles, videos and blog posts, averaging more than 90 pieces of overall content with topics ranging from kid-friendly travel tips to easy workplace exercises.
The summer campaign will be supported in-store with POP, consumer emails and in-store radio along with owned and social media. In addition, television, radio and digital advertising will support the in-store and online contest communicating offers.
Dollar General Literacy Foundation awards more than $6 million in grants
GOODLETTSVILLE, Tenn. — The Dollar General Literacy Foundation on Friday announced the award of more than $6 million in grants to 700 schools, nonprofits and literacy organizations across the 40 states Dollar General serves to support adult, family and summer literacy programs.
"At Dollar General, we are passionate about our mission of Serving Others throughout the communities we serve," stated Rick Dreiling, Dollar General’s chairman and CEO. "It’s exciting to see the Dollar General Literacy Foundation’s outreach in action as we partner with organizations to further education and literacy and make a real difference in people’s lives.
Since its inception in 1993, the Dollar General Literacy Foundation has awarded more than $92 million in grants to nonprofit organizations, helping more than 5 million individuals take steps toward literacy or continued education.
Abbott acquires CFR Pharmaceuticals in deal worth $3.3 billion
ABBOTT PARK, Ill. — Abbott on Friday announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence the company reported.
Under the terms of the agreement, Abbott will acquire the holding company that indirectly owns approximately 73% of CFR Pharmaceuticals and will conduct a public cash tender offer for all of the outstanding shares of CFR. Assuming all publicly-held shares are tendered, the total purchase price would be approximately $2.9 billion, plus the assumption of net debt of approximately $430 million.
This acquisition immediately establishes Abbott among the top 10 pharmaceutical companies in Latin America, further broadening Abbott’s geographic presence across the region, the company stated.
"With its scale and leadership positions in the region, strong commercial and development organizations, well-respected leadership team and a trusted portfolio of recognized brands, CFR is one of the leading branded generic companies in Latin America," stated Miles White, chairman and CEO Abbott. "This acquisition will significantly enhance and broaden Abbott’s Latin American footprint, and is well aligned with our long-term strategy and commitment to fast-growing markets."
Abbott expects the acquisition to add approximately $900 million to its sales in the first full year (2015), with expected double-digit sales growth over the next several years.
CFR Pharmaceuticals, headquartered in Santiago, Chile, participates in 15 Latin American markets and has a product portfolio that is well aligned with Abbott’s current pharmaceutical therapeutic areas of focus in women’s health, central nervous system, cardiovascular and respiratory diseases, the company noted.
CFR currently markets more than 1,000 products.
The Latin American pharmaceutical market is expected to reach $73 billion in sales this year, and is expected to reach $124 billion by 2018, with estimated annual growth rates of two to three times that of developed markets over the coming years, according to IMS forecasts.